<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1759563</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2026.1759563</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Glycolysis-related gene signatures in spinal cord injury pathophysiology identification through integrative gene expression analysis</article-title>
<alt-title alt-title-type="left-running-head">Liu et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2026.1759563">10.3389/fgene.2026.1759563</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Xiaoqin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Zhuang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Jiating</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Guodong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ai</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3291549"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Yan&#x2019;an Medical College of Yan&#x2019;an University</institution>, <city>Yan&#x2019;an</city>, <country country="CN">China</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Department of Radiology, The Affiliated Hospital of Yan&#x2019;an University</institution>, <city>Yan&#x2019;an</city>, <country country="CN">China</country>
</aff>
<aff id="aff3">
<label>3</label>
<institution>Department of Neurosurgery, The Affiliated Hospital of Yan&#x2019;an University</institution>, <city>Yan&#x2019;an</city>, <country country="CN">China</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Xin Ai, <email xlink:href="mailto:15319557018@sina.cn">15319557018@sina.cn</email>
</corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-16">
<day>16</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>17</volume>
<elocation-id>1759563</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>27</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Liu, Wang, Hu, Shi and Ai.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Liu, Wang, Hu, Shi and Ai</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-16">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Spinal cord injury (SCI) is a debilitating condition that significantly impacts patients&#x2019; mobility and quality of life, posing a substantial economic burden on healthcare systems. Increasing evidence suggests that metabolic reprogramming, particularly glycolysis, is involved in inflammatory responses following SCI. This study aims to systematically investigate the association between the role of glycolysis-related genes (GRGs) and SCI, and to identify potential candidate biomarkers.</p>
</sec>
<sec>
<title>Methods</title>
<p>The GSE151371 dataset was retrieved from the Gene Expression Omnibus (GEO) to identify differentially expressed genes (DEGs), which were subsequently subjected to Weighted Gene Co-expression Network Analysis (WGCNA) to pinpoint glycolysis-associated modules. Hub genes associated with SCI were initially identified through machine learning algorithms and subsequently evaluated using the independent GSE45006 dataset. Immune infiltration in SCI was profiled by single-sample gene set enrichment analysis (ssGSEA) and correlated with hub gene expression. After establishing TF-miRNA-mRNA and protein-chemical networks, hub gene expression patterns were characterized by scRNA-seq and further validated experimentally <italic>in vivo</italic> by qRT-PCR and Western blotting.</p>
</sec>
<sec>
<title>Results</title>
<p>From 1,138 DEGs, WGCNA identified 704 in glycolysis-associated modules. Intersecting these with GRGs yielded 13 candidates. Subsequent machine learning pinpointed six hub genes (<italic>ALK</italic>, <italic>GGH</italic>, <italic>IRS1</italic>, <italic>PPARG</italic>, <italic>SLC1A3</italic>, <italic>UBTD1</italic>), of which only <italic>IRS1</italic> and <italic>UBTD1</italic> showed consistent expression patterns in an external dataset. ssGSEA identified 20 differentially abundant immune cell types in SCI. Subsequently, <italic>IRS1</italic> expression was associated with activated T cells and natural killer (NK) cells, while <italic>UBTD1</italic> expression correlated with activated dendritic cells, monocytes, and neutrophils. scRNA-seq revealed that <italic>Irs1</italic> was mainly expressed in endothelial and epithelial cells, while <italic>Ubtd1</italic> was broadly expressed, with higher levels in endothelial cells and microglia. qRT-PCR revealed significant upregulation of <italic>Ubtd1</italic> in the SCI group, whereas <italic>Irs1</italic> expression did not differ significantly. Western blot further confirmed elevated UBTD1 protein levels in SCI compared with the Sham group.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Our integrative transcriptomic and experimental analyses suggest that <italic>UBTD1</italic>, a glycolysis-related gene, as significantly associated with SCI and immune cell infiltration, highlighting its potential as a biomarker and suggesting its role in metabolic&#x2013;immune interactions post-SCI.</p>
</sec>
</abstract>
<kwd-group>
<kwd>glycolysis</kwd>
<kwd>immune microenvironment</kwd>
<kwd>machine learning</kwd>
<kwd>single cell</kwd>
<kwd>spinal cord injury</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This study was funded by Research Project of Yan&#x2019;an University (205040592).</funding-statement>
</funding-group>
<counts>
<fig-count count="9"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="53"/>
<page-count count="16"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Computational Genomics</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<label>1</label>
<title>Introduction</title>
<p>Spinal cord injury (SCI) represents a major public health challenge, as it results in significant lifelong disabilities and imposes a considerable economic burden on healthcare systems and society (<xref ref-type="bibr" rid="B9">Crispo et al., 2023</xref>). The intricate nature of SCI, characterized by a cascade of biological events following initial trauma, necessitates a comprehensive understanding of its underlying mechanisms to develop effective therapeutic strategies (<xref ref-type="bibr" rid="B1">Ahuja et al., 2017</xref>; <xref ref-type="bibr" rid="B53">Zheng and Tuszynski, 2023</xref>). Despite advancements in medical interventions, including surgical options and rehabilitation therapies, the restoration of function and improvement in the quality of life for affected individuals remain limited (<xref ref-type="bibr" rid="B21">Hu et al., 2023</xref>). Therefore, there is an urgent need for innovative research that delves into the molecular alterations that accompany SCI and their potential therapeutic implications. Glycolysis, a fundamental metabolic pathway for energy production in cells, has increasingly been recognized as a key modulator of neuroinflammatory responses mediated by microglia (<xref ref-type="bibr" rid="B22">Hua et al., 2024</xref>; <xref ref-type="bibr" rid="B47">Yu et al., 2023</xref>). In response to pathological stimuli, such as SCI and neurodegenerative diseases, microglia undergo extensive shifts in their metabolic profile (<xref ref-type="bibr" rid="B37">Sabogal-Gu&#xe1;queta et al., 2023</xref>). Previous studies have identified a clear association between the M1 polarization of microglia and an upregulation of glycolytic activity in the context of SCI (<xref ref-type="bibr" rid="B14">Ding et al., 2025</xref>). After the onset of primary SCI, the affected microenvironment rapidly experiences ischemia and hypoxia, which triggers a metabolic switch in microglia, infiltrating macrophages, and astrocytes, from oxidative phosphorylation to glycolysis (<xref ref-type="bibr" rid="B47">Yu et al., 2023</xref>; <xref ref-type="bibr" rid="B36">Orihuela et al., 2016</xref>; <xref ref-type="bibr" rid="B42">Viola et al., 2019</xref>). Although this metabolic shift initially supports the increased energy requirements of activated immune cells, prolonged activation of this pathway amplifies the inflammatory response via several mechanisms. This implies that targeting metabolic reprogramming may offer a promising approach for therapeutic intervention.</p>
<p>To address these gaps in knowledge, our study employs a multifaceted methodological approach that integrates large-scale gene expression datasets, advanced analytical techniques such as weighted gene co-expression network analysis (WGCNA) and machine learning algorithms. This comprehensive strategy is designed to elucidate the intricate relationships between glycolysis-related genes (GRGs) and SCI, thereby identifying potential biomarkers and therapeutic targets. The primary objective of this research is to elucidate the specific roles of GRGs in the context of SCI and to assess their potential as therapeutic targets. By analyzing the SCI-related datasets from GEO and employing rat models, we examined the expression patterns of GRGs and their contribution to risk evaluation in the context of SCI progression, with a particular emphasis on the modulation of immune microenvironments (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Overview of the study workflow.</p>
</caption>
<graphic xlink:href="fgene-17-1759563-g001.tif">
<alt-text content-type="machine-generated">Flowchart showing a research process starting with GSE151371 dataset, identifying DEGs, performing glycolysis score and WGCNA, integrating with GRGs, identifying 13 DE-GRGs, applying machine learning to find 6 hub genes, validating with GSE45006, narrowing to 2 hub genes, followed by single-cell analysis with ssGSEA, experimental verification in vivo, and miRNA-gene-TF and protein-chemical analysis.</alt-text>
</graphic>
</fig>
</sec>
<sec sec-type="materials|methods" id="s2">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2-1">
<label>2.1</label>
<title>Data acquisition</title>
<p>Datasets GSE151371, GSE45006, and GSE162610 were sourced from the GEO (Gene Expression Omnibus) database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>) (<xref ref-type="bibr" rid="B15">Edgar et al., 2002</xref>). The GSE151371 dataset includes gene expression profiles of peripheral white blood cells (WBCs) along with clinical data from 38 SCI patients and 10 healthy individuals (<xref ref-type="bibr" rid="B26">Kyritsis et al., 2021</xref>). Probes were mapped to their respective gene symbols using the annotation information from the GPL20301 [Illumina HiSeq 4,000 (<italic>Homo sapiens</italic>)] platform. The GSE45006 microarray expression dataset for SCI rats was generated using the GPL1355 [Rat230_2] Affymetrix Rat Genome 230 2.0 Array platform. In this dataset, SCI was induced in rats using an aneurysm clip impact-compression injury model on the thoracic spinal cord (T7). This dataset includes the Sham group (n &#x3d; 4) and the SCI group, with samples collected at 1, 3, and 7 days post-injury (n &#x3d; 4 per time point). Although GSE151371 and GSE45006 differ in species and tissue origin, GSE45006 was incorporated as a supportive external validation dataset to assess the consistency of glycolysis-related gene expression patterns at the transcriptomic and pathway levels, rather than to establish direct tissue or species equivalence. The scRNA-seq dataset GSE162610 includes data from normal and injured spinal cords at 1, 3, and 7 days post-injury of wild-type mice. This dataset was used to characterize the cellular distribution of candidate hub genes within the spinal cord microenvironment, thereby providing complementary cell-type&#x2013;specific context for the transcriptomic findings derived from bulk RNA-seq analysis.</p>
<p>The GeneCards database (<ext-link ext-link-type="uri" xlink:href="https://www.genecards.org/">https://www.genecards.org/</ext-link>) provides extensive gene information for humans (<xref ref-type="bibr" rid="B39">Stelzer et al., 2016</xref>). By searching with the keyword &#x201c;glycolysis&#x201d;, we selected genes classified as &#x2018;Protein Coding&#x2019; and with a relevance score exceeding 1.00, thereby identifying glycolysis-related genes (GRGs). This search resulted in the identification of 1,572 GRGs, which are listed in <xref ref-type="sec" rid="s13">Supplementary Table S1</xref>.</p>
</sec>
<sec id="s2-2">
<label>2.2</label>
<title>PCA-based calculation of glycolysis score</title>
<p>To quantify glycolytic transcriptional activity in each sample, a predefined set of glycolysis-related genes was extracted from the transcriptomic data, and principal component analysis (PCA) was performed using the expression matrix of these genes. PCA identifies orthogonal linear combinations of genes that successively maximize variance within the selected gene set. In this study, the first two principal components (PC1 and PC2) captured the dominant axes of coordinated transcriptional variation among glycolysis-related genes. As PC1 and PC2 together explained the majority of the variance within this gene set, a composite glycolysis score was constructed by summing the PC1 and PC2 scores for each sample. This PCA-based score was used as an empirical measure to summarize overall glycolytic transcriptional activity, consistent with previous studies (<xref ref-type="bibr" rid="B40">Sun et al., 2021</xref>). This score summarizes coordinated transcriptional variation within GRGs.</p>
</sec>
<sec id="s2-3">
<label>2.3</label>
<title>Weighted gene Co-expression network analysis (WGCNA)</title>
<p>In this study, WGCNA was used to identify gene modules strongly associated with glycolysis, utilizing the &#x201c;WGCNA&#x201d; package (version 1.73) in R software (<xref ref-type="bibr" rid="B28">Langfelder and Horvath, 2008</xref>). Hierarchical clustering was applied to the study samples to identify and exclude outliers. A soft-thresholding power of &#x3b2; &#x3d; 12 was chosen to build a scale-free network and compute the topological overlap matrix. The correlation between each module and the glycolysis score was evaluated. Modules with a high correlation coefficient were identified as key modules strongly associated with glycolysis. A correlation coefficient exceeding 0.5 and a significance level of <italic>P</italic> &#x3c; 0.05 were set as the criteria for module-phenotype correlation. Genes from the key module were compared with glycolysis-related genes and DEGs, leading to the identification of a set of glycolysis-associated DEGs (GR-DEGs).</p>
</sec>
<sec id="s2-4">
<label>2.4</label>
<title>Screening of DEG</title>
<p>The raw GEO data was normalized using the &#x2018;NormalizeBetweenArray&#x2019; function in R. Differentially expressed genes (DEGs) between the HC and SCI groups in the GSE151371 dataset were identified using the &#x201c;Limma&#x201d; package, which was found to be the most efficient tool. A log fold change (LogFC) threshold of &#x3e;0.5 and an adjusted <italic>P</italic>-value &#x003c;0.05 were applied to determine gene differential expression.</p>
</sec>
<sec id="s2-5">
<label>2.5</label>
<title>Identification of feature genes using machine learning algorithms</title>
<p>In this study, we utilized the Bagged Trees, Bayesian Networks, Support Vector Machine (SVM), Random Forest, XGBoost, Boruta, Learning Vector Quantization (LVQ), and 1,000 iterations of 10-fold cross-validation with Least Absolute Shrinkage and Selection Operator (LASSO) algorithms to pinpoint the key genes linked to glycolysis. Genes that were consistently recognized as feature genes by at least 7 different algorithms, based on their classification efficacy, were classified as key hub genes involved in the interaction between SCI and glycolysis. The interactions between these crucial intersecting genes were subsequently visualized using the &#x201c;Upset&#x201d; application from the R package. It should be noted that these machine learning algorithms were used for feature selection and robustness assessment rather than for constructing a single optimized predictive classifier.</p>
</sec>
<sec id="s2-6">
<label>2.6</label>
<title>Pathway analysis of the two hub genes</title>
<p>To investigate the regulatory pathways and biological functions linked to the two hub genes, single-gene GSEA analysis was conducted. A significance threshold of adjusted <italic>P</italic>-value &#x3c;0.05 was applied. The top five enriched pathways for both upregulated and downregulated genes were displayed separately, based on their enrichment scores.</p>
</sec>
<sec id="s2-7">
<label>2.7</label>
<title>TF&#x2013;miRNA regulatory interaction network</title>
<p>Transcription factors (TFs) are proteins that interact with DNA at specific sequences to control the process of transcription. Through their ability to recognize unique DNA motifs, TFs influence chromatin configuration and transcriptional activity, orchestrating the regulation of gene expression across the genome (<xref ref-type="bibr" rid="B27">Lambert et al., 2018</xref>). MicroRNAs (miRNAs) are a class of short, endogenous non-coding RNAs that regulate gene expression by either degrading target mRNAs or preventing their translation (<xref ref-type="bibr" rid="B4">Bartel, 2004</xref>). To elucidate the dysregulation of gene expression in diverse physiological and disease contexts, it is essential to explore the intricate transcriptional regulatory networks that govern the interactions between TFs and miRNAs (<xref ref-type="bibr" rid="B4">Bartel, 2004</xref>; <xref ref-type="bibr" rid="B48">Zaborowski and Walther, 2020</xref>; <xref ref-type="bibr" rid="B23">Iwama et al., 2011</xref>). NetworkAnalyst (<ext-link ext-link-type="uri" xlink:href="http://www.networkanalyst.ca">http://www.networkanalyst.ca</ext-link>) is an online tool designed for advanced meta-analysis of gene expression data (<xref ref-type="bibr" rid="B44">Xia et al., 2015</xref>). <italic>IRS1</italic> and <italic>UBTD1</italic> were analyzed using NetworkAnalyst to construct a TF&#x2013;miRNA coregulatory network. Regulatory interaction data curated from the literature were gathered from RegNetwork (<ext-link ext-link-type="uri" xlink:href="http://www.regnetworkweb.org/">http://www.regnetworkweb.org/</ext-link>) (<xref ref-type="bibr" rid="B32">Liu et al., 2015</xref>). The relevant results were visualized using Cytoscape.</p>
</sec>
<sec id="s2-8">
<label>2.8</label>
<title>Interactions between proteins and chemicals</title>
<p>Using the NetworkAnalyst platform, compounds that interact with the hub genes were retrieved from The Comparative Toxicogenomics Database (CTD), and a protein-chemical interaction network was then built based on these interactions. Cytoscape was employed to visualize the relevant results.</p>
</sec>
<sec id="s2-9">
<label>2.9</label>
<title>Single-cell RNA sequencing data processing and analysis</title>
<p>The analysis of single-cell RNA sequencing data was mainly carried out using the &#x201c;Seurat (v 5.1.0)&#x201d; package (<xref ref-type="bibr" rid="B19">Hao et al., 2021</xref>). To maintain data quality, cells with fewer than 200 detected genes or more than 20% mitochondrial gene content were excluded. Batch effects were corrected using the &#x201c;Harmony&#x201d; package (v.1.2.1) (<xref ref-type="bibr" rid="B25">Korsunsky et al., 2019</xref>). Data normalization was performed using the &#x2018;lognormalization&#x2019; function, and highly variable genes were selected with the &#x2018;FindVariableFeatures&#x2019; function. We applied the tSNE algorithm to classify cell types, generating a unified map that reveals structural patterns across various scales, making it especially valuable for high-dimensional data. Clustering was performed with the Louvain algorithm, and marker genes specific to each cell subpopulation were identified through the &#x2018;FindAllMarkers&#x2019; function. Cell type annotation was initially carried out automatically using the &#x201c;SingleR&#x201d; package.</p>
</sec>
<sec id="s2-10">
<label>2.10</label>
<title>Animal model</title>
<p>The animals used in this study were sourced from the Laboratory Animal Center at Xi&#x2019;an Jiaotong University (Animal License No. SCXC [Shan] 2023&#x2013;002). All experimental protocols were approved by the Animal Ethics Committee of Yan&#x2019;an University and carried out in strict compliance with both institutional and national regulations governing the ethical treatment and use of animals. A total of 12 female Sprague Dawley (SD) rats (8 weeks old) were randomly assigned to two groups: the Sham group and the SCI group. In the Sham group, a laminectomy was performed without inducing spinal cord injury. The SCI model was created following a modified version of the Allen method, as outlined in the existing literature (<xref ref-type="bibr" rid="B33">Liu et al., 2021</xref>). Briefly, the animals were anesthetized by intraperitoneal injection of 1% pentobarbital sodium (40&#xa0;mg/kg, intraperitoneal injection), and then positioned on a surgical table. The T10 vertebra was exposed by removing the lamina using bone cutting forceps. To induce the injury, a 10&#xa0;g weight was dropped from a height of 3&#xa0;cm directly onto the exposed spinal cord. To prevent infection, penicillin (Dingjian, Sichuan, China) was administered subcutaneously for three consecutive days at a daily dose of 2.5&#xa0;mg/kg. Bladder voiding was manually facilitated twice daily through the application of abdominal pressure until the animals were able to urinate spontaneously. Seventy-two hours following SCI induction, the SD rats were anesthetized through an overdose of 1% pentobarbital sodium administered via intraperitoneal injection. A segment of spinal cord tissue, 1.5&#xa0;cm in length from the center of the injury site, was carefully excised for further analysis.</p>
</sec>
<sec id="s2-11">
<label>2.11</label>
<title>RNA extraction and qRT-PCR analysis</title>
<p>Total RNA was isolated from spinal tissues using the TRIzol Total RNA Purification Kit (5003050, Simgen, China), and cDNA synthesis was carried out with the NovoScript&#xae; Plus All-in-one 1st Strand cDNA Synthesis SuperMix (E047-01A, Novoprotein, China). Target gene expression was quantified using the NovoStart&#xae; SYBR qPCR SuperMix Plus (E096-01A, Novoprotein, China). The relative expression levels were normalized to &#x3b2;-actin and calculated using the 2<sup>&#x2212;&#x394;&#x394;Ct</sup> method. The primer sequences are presented in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Primers used in quantitative real-time PCR analysis.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Gene</th>
<th align="center">Sequence (5&#x2032;&#x2013;3&#x2032;)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">
<italic>Irs1</italic>
</td>
<td align="left">Forward: CTG&#x200b;CAT&#x200b;AAT&#x200b;CGG&#x200b;GCA&#x200b;AAG&#x200b;GC</td>
</tr>
<tr>
<td align="left">&#x200b;</td>
<td align="left">Reverse: GCC&#x200b;CGT&#x200b;GTC&#x200b;ATA&#x200b;GCT&#x200b;CAA&#x200b;GT</td>
</tr>
<tr>
<td align="center">
<italic>Ubtd1</italic>
</td>
<td align="left">Forward: GTT&#x200b;GGG&#x200b;TAA&#x200b;GTC&#x200b;AGG&#x200b;TCG&#x200b;CA</td>
</tr>
<tr>
<td align="left">&#x200b;</td>
<td align="left">Reverse: AGG&#x200b;GCA&#x200b;TCC&#x200b;CAG&#x200b;ATC&#x200b;TCC&#x200b;TT</td>
</tr>
<tr>
<td align="center">&#x3b2;-actin</td>
<td align="left">Forward: CCC&#x200b;ATC&#x200b;TAT&#x200b;GAG&#x200b;GGT&#x200b;TAC&#x200b;GC</td>
</tr>
<tr>
<td align="left">&#x200b;</td>
<td align="left">Reverse: TTT&#x200b;AAT&#x200b;GTC&#x200b;ACG&#x200b;CAC&#x200b;GAT&#x200b;TTC</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-12">
<label>2.12</label>
<title>Western blotting</title>
<p>Proteins were extracted from spinal tissues, and their concentrations were quantified using the BCA method. The extracted proteins were separated by SDS-PAGE and subsequently transferred to a PVDF membrane (Merck, Germany). The membrane was blocked with 5% skimmed milk for 1&#xa0;h to prevent non-specific binding. Primary antibodies were applied to the membrane overnight, including rabbit anti-UBTD1 (1:1,000 dilution, DF15663, Affinity) and rabbit anti-&#x3b2;-Tubulin (1:4,000 dilution, YM8332, ImmunoWay). Following washing steps, the membrane was incubated with HRP-conjugated goat anti-rabbit IgG (H &#x2b; L) (1:10,000 dilution, GB111738-100, Servicebio) for 2&#xa0;h at room temperature. After additional washing, the protein bands were visualized using ECL reagent, and the results were captured and documented using a chemiluminescence imaging system.</p>
</sec>
<sec id="s2-13">
<label>2.13</label>
<title>Statistical analysis</title>
<p>All analyses were conducted using R version 4.2.1. Data are presented as means &#xb1; standard error of the mean (SEM) from at least three independent experiments and were analyzed using GraphPad Prism 9.3.1. The Wilcoxon rank-sum test and Welch&#x2019;s t-test were employed to compare the expression differences between unpaired samples from the two groups. <italic>P</italic>-values were interpreted according to the following scale of significance: asterisks denote increasing levels of significance (&#x2a;<italic>P</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>P</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>P</italic> &#x3c; 0.001), while &#x2018;ns&#x2019; denotes non-significance.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<label>3</label>
<title>Results</title>
<sec id="s3-1">
<label>3.1</label>
<title>Construction of weighted gene Co-expression network</title>
<p>PCA was performed based on the expression of GRGs to calculate the glycolysis score for each sample. The glycolysis score was significantly higher in SCI samples compared to HC samples (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Using the GSE151371 dataset from GEO, clustering analysis was carried out, and a soft-thresholding power of &#x3b2; &#x3d; 12 was chosen, ensuring an <italic>R</italic>
<sup>2</sup> value greater than 0.9 and a relatively high mean connectivity (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Under the parameter settings of minModuleSize &#x3d; 100 and mergeCutHeight &#x3d; 0.25, six modules were identified (<xref ref-type="fig" rid="F2">Figures 2C,D</xref>). The MEbrown module demonstrated the strongest correlation with the score, exhibiting a correlation coefficient of r &#x3d; 0.76 and a <italic>P</italic>-value of 3.42e-10, as shown in <xref ref-type="fig" rid="F2">Figure 2E</xref>. Moreover, the GS and MM values in the brown module were strongly correlated, suggesting that this module exhibited the most significant association with glycolysis (<xref ref-type="fig" rid="F2">Figure 2F</xref>). Based on this, we selected the MEbrown module, which consists of 704 genes, as the key module for further analysis.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Identification of glycolysis-related modules through WGCNA. <bold>(A)</bold> Glycolysis scores between SCI and HC samples. <bold>(B)</bold> The scale-free topology model fit index as a function of the soft-thresholding power was plotted. A soft-thresholding power of 12 was selected to maintain a scale-free topology in the network construction. <bold>(C)</bold> Clustering was conducted using the transcriptome data from the GSE151371 dataset, where color intensity indicates the glycolysis scores. <bold>(D)</bold> Coexpression modules were identified through hierarchical clustering, with unique colors assigned to each module. In the resulting dendrogram, each branch corresponds to a gene, and genes that cluster together are assigned the same module color. <bold>(E)</bold> A heatmap of module-trait associations showing the link between modules and glycolysis scores. Positive correlations are depicted in red, whereas negative correlations are shown in blue. <bold>(F)</bold> Correlation analysis was performed between module membership (MM) in the brown module and gene significance (GS) for glycolysis.</p>
</caption>
<graphic xlink:href="fgene-17-1759563-g002.tif">
<alt-text content-type="machine-generated">Panel A displays a violin plot comparing glycolysis pathway scores between healthy controls and SCI groups, with SCI showing significantly higher values. Panel B includes two line graphs showing scale independence analysis and mean connectivity for different soft threshold powers in network construction. Panel C shows a sample dendrogram with a heatmap indicating glycolysis scores across samples. Panel D presents a gene dendrogram colored by module assignment using hierarchical clustering. Panel E contains a heatmap of module-trait relationships, reporting correlation values and p-values between gene modules and glycolysis score. Panel F is a scatterplot showing a strong positive correlation between gene significance for glycolysis and module membership in the brown module.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-2">
<label>3.2</label>
<title>Comparative analysis of GRG expression in SCI and HC samples</title>
<p>Differential expression analysis of the GSE151371 dataset identified a total of 1,138 DEGs, with 707 genes being upregulated and 431 genes downregulated, as depicted in the volcano plot (<xref ref-type="fig" rid="F3">Figure 3A</xref>). By intersecting the key WGCNA module genes, DEGs, and GRGs, a total of 13&#xa0;GR-DEGs were identified (<xref ref-type="fig" rid="F3">Figure 3B</xref>). Additionally, a heatmap was generated to illustrate the expression patterns of the 13&#xa0;GR-DEGs. The results showed that <italic>ALK</italic> and <italic>IRS1</italic> were downregulated, while <italic>PPARG</italic>, <italic>SLC1A3</italic>, <italic>GCKR</italic>, <italic>KL</italic>, <italic>UBTD1</italic>, <italic>GGH</italic>, <italic>GPR87</italic>, <italic>ANO5</italic>, <italic>SCO2</italic>, <italic>DHCR7</italic>, and <italic>HMGB3</italic> were upregulated in SCI (<xref ref-type="fig" rid="F3">Figure 3C</xref>). The positions of the 13&#xa0;GR-DEGs on the chromosomes were mapped using the &#x201c;RCircos&#x201d; package for visualization (<xref ref-type="fig" rid="F3">Figure 3D</xref>) (<xref ref-type="bibr" rid="B50">Zhang et al., 2013</xref>). The correlation analysis of the 13&#xa0;GR-DEGs revealed significant interconnections among these genes, indicating a strong mutual correlation. As shown in <xref ref-type="fig" rid="F3">Figures 3E&#x2013;G</xref>, the correlation heatmap illustrates the overall relationships among the 13 GR-DEGs, while <xref ref-type="fig" rid="F3">Figures 3F,G</xref> display the strongest positive and negative correlations, respectively.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Expression profiles of GRGs in SCI and HC samples. <bold>(A)</bold> A volcano plot illustrating the DEGs in the GSE151371 dataset, selected based on the thresholds &#x7c;log2FC&#x7c; &#x3e; 0.5 and adjusted <italic>P</italic>-value &#x003c;0.05, comparing SCI patients to HC. <bold>(B)</bold> A Venn diagram was employed to identify DEGs associated with glycolysis. <bold>(C)</bold> Heatmap showing the expression of GR-DEGs between SCI and HC. <bold>(D)</bold> Chromosomal locations of the 13&#xa0;GR-DEGs. <bold>(E)</bold> Spearman correlation analysis of the 13&#xa0;GR-DEGs in SCI samples. <bold>(F,G)</bold> Scatterplots were used to illustrate the strongest correlations among the 13&#xa0;GR-DEGs: KL and SLC1A3 exhibited a positive correlation, while PPARG and ALK showed a negative correlation.</p>
</caption>
<graphic xlink:href="fgene-17-1759563-g003.tif">
<alt-text content-type="machine-generated">Panel A displays a volcano plot showing differentially expressed genes with log fold change on the x-axis and -log10 p-value on the y-axis; Panel B shows a Venn diagram comparing gene sets labeled DEGs, GRGs, and WGCNA with their overlaps quantified; Panel C presents a clustered heatmap of gene expression across samples and groups; Panel D features a circular ideogram map of the human genome with gene locations marked; Panel E displays a correlation matrix visualizing pairwise correlations between genes as colored semicircles; Panel F is a scatter plot with regression analysis for KL and SLC6A3 gene expression; Panel G is a scatter plot with regression analysis for PPARG and ALK gene expression.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-3">
<label>3.3</label>
<title>Key genes were identified through the application of machine learning</title>
<p>The GSE151371 dataset was used to apply machine learning, which facilitated the identification of 13&#xa0;GR-DEGs associated with the SCI. The intersection of findings from various machine learning algorithms, including Lasso-Logistic regression with 1,000 iterations (<xref ref-type="fig" rid="F4">Figure 4A</xref>), the LVQ algorithm (<xref ref-type="fig" rid="F4">Figure 4B</xref>), Boruta (<xref ref-type="fig" rid="F4">Figure 4C</xref>), Bagged Trees (<xref ref-type="fig" rid="F4">Figure 4D</xref>), Random Forest (<xref ref-type="fig" rid="F4">Figure 4E</xref>), Bayesian Networks (<xref ref-type="fig" rid="F4">Figure 4F</xref>), SVM (<xref ref-type="fig" rid="F4">Figure 4G</xref>), and XGBoost (<xref ref-type="fig" rid="F4">Figure 4H</xref>), revealed six genes that are significantly associated with the interaction between SCI and glycolysis (<xref ref-type="fig" rid="F4">Figure 4I</xref>). These genes are <italic>ALK</italic>, <italic>GGH</italic>, <italic>IRS1</italic>, <italic>PPARG</italic>, <italic>SLC1A3</italic>, and <italic>UBTD1</italic>. To validate the six hub genes, the GSE45006 dataset was utilized, and the analysis demonstrated that only <italic>Irs1</italic> and <italic>Ubtd1</italic> exhibited significant differential expression between the SCI and Sham groups (<xref ref-type="fig" rid="F4">Figure 4J</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Machine learning approaches were employed to investigate the hub genes involved in the interactions between SCI and glycolysis. The outcomes from the application of various machine learning algorithms to the GSE151371 dataset are illustrated as follows: LASSO <bold>(A)</bold>, LVQ <bold>(B)</bold>, Boruta <bold>(C)</bold>, Bagged Tree <bold>(D)</bold>, Random Forest <bold>(E)</bold>, Bayesian <bold>(F)</bold>, SVM <bold>(G)</bold>, and XGBoost <bold>(H)</bold>. Panel <bold>(I)</bold> provides a summary of the hub genes identified as pivotal for the interactions between SCI and glycolysis by all eight machine learning algorithms. <bold>(J)</bold> The expression of Irs1 and Ubtd1 were validated in the dataset GSE45006. Data are presented as mean &#xb1; SEM. &#x2a;<italic>P</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>P</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>P</italic> &#x3c; 0.001; ns, not significant.</p>
</caption>
<graphic xlink:href="fgene-17-1759563-g004.tif">
<alt-text content-type="machine-generated">Panel A presents a bar chart showing model frequency by number of genes, panel B is a horizontal bar graph ranking gene importance using LVQ, and panel C is a Boruta boxplot ranking gene relevance. Panels D to H are scatter or line plots comparing classifier accuracy for TreeBag, Random Forest, Bayesian, SVM, and XGBoost models respectively. Panel I is an UpSet plot displaying intersection sizes among gene sets, and panel J is a violin plot validating gene expression levels in sham versus SCI groups from the GSE45006 dataset.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-4">
<label>3.4</label>
<title>Immune cell infiltration</title>
<p>The relative abundance of 28 immune cell types was quantitatively evaluated using the ssGSEA method, and comparisons were conducted between the SCI and HC groups based on the peripheral blood transcriptomic data. Significant disparities in the abundance of 20 immune cell types between the two groups were identified through the Wilcoxon rank-sum test. Specifically, the SCI group showed significantly higher infiltration levels of activated dendritic cells, CD56dim natural killer cells, central memory CD4 T cells, gamma delta T cells, macrophages, monocytes, neutrophils, and regulatory T cells. In contrast, the infiltration levels of activated B cells, activated CD8 T cells, CD56bright natural killer cells, effector memory CD8 T cells, immature B cells, memory B cells, natural killer cells, natural killer T cells, T follicular helper cells, type 1&#xa0;T helper cells, type 17&#xa0;T helper cells, and type 2&#xa0;T helper cells were significantly lower (<xref ref-type="fig" rid="F5">Figure 5A</xref>). Further correlation analysis revealed a significant positive correlation between <italic>IRS1</italic> and the abundance of activated CD8 T cells, CD56bright natural killer cells, gamma delta T cells, and T follicular helper cells in SCI (<xref ref-type="fig" rid="F5">Figure 5B</xref>). Additionally, <italic>UBTD1</italic> showed a significant positive correlation with activated dendritic cells, monocytes, and neutrophils, while demonstrating a negative correlation with activated CD8 T cells, effector memory CD8 T cells, immature B cells, memory B cells, and type 2&#xa0;T helper cells in SCI (<xref ref-type="fig" rid="F5">Figure 5B</xref>). These findings reveal distinct alterations in immune cell populations within systemic circulation of SCI patients, suggesting a potential link between systemic immune responses and the identified hub genes.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Analysis of immune infiltration levels associated with the two hub genes. <bold>(A)</bold> ssGSEA enrichment analysis to assess the differential expression of immune cells between SCI and HC samples. <bold>(B)</bold> The correlation between the two hub genes and immune cells in SCI. Data are presented as mean &#xb1; SEM. &#x2a;<italic>P</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>P</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>P</italic> &#x3c; 0.001; ns, not significant.</p>
</caption>
<graphic xlink:href="fgene-17-1759563-g005.tif">
<alt-text content-type="machine-generated">Panel A displays a violin plot comparing immune cell infiltration levels across multiple cell types between healthy controls (HC, blue) and spinal cord injury (SCI, red) groups, with statistical significance indicated above each comparison. Panel B shows a heatmap illustrating correlations between selected genes (UBTD1, IRS1) and immune cell infiltration levels, using a color scale from blue (negative) to red (positive), with significance indicated by asterisks.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-5">
<label>3.5</label>
<title>Analysis of pathways associated with the two hub genes</title>
<p>A single-gene GSEA analysis was performed to explore the biological functions and associated pathways of the two candidate hub genes. The upregulation of <italic>IRS1</italic> is linked to immune-related pathways, platelet-specific genes, and translation initiation processes (<xref ref-type="fig" rid="F6">Figure 6A</xref>). The downregulation of <italic>IRS1</italic> is associated with immune functions, neutrophil activity, and the regulation of myeloid cells (<xref ref-type="fig" rid="F6">Figure 6B</xref>). These findings underscore the diverse biological functions of <italic>IRS1</italic> in regulating both immune and cellular activities. The upregulation of <italic>UBTD1</italic> is associated with immune response regulation, neutrophil activity, and cancer cell proliferation, particularly in the context of infection and cancer (<xref ref-type="fig" rid="F6">Figure 6C</xref>). The downregulation of <italic>UBTD1</italic> is linked to immune response mechanisms, particularly cytokine signaling and interferon pathways, while also being linked to diseases like Sezary syndrome and melanoma (<xref ref-type="fig" rid="F6">Figure 6D</xref>). These results emphasize the broad and complex roles of <italic>IRS1</italic> and <italic>UBTD1</italic> in regulating immune and cellular activities across different biological contexts.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Pathway and functional analysis of the two hub genes. <bold>(A,B)</bold> The top five pathways positively correlated with <italic>IRS1</italic> and <italic>UBTD1</italic>. <bold>(C,D)</bold> The top five pathways negatively correlated with <italic>IRS1</italic> and <italic>UBTD1</italic>.</p>
</caption>
<graphic xlink:href="fgene-17-1759563-g006.tif">
<alt-text content-type="machine-generated">Four-panel scientific figure displays enrichment plots for IRS1 and UBTD1 gene regulation. Panels A and B show results for IRS1 up-regulation and down-regulation; panels C and D show UBTD1 up-regulation and down-regulation. Each plot charts running enrichment scores for multiple gene sets, with gene set legends, tick marks for gene ranks, and gray distribution plots indicating ranked list metrics.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-6">
<label>3.6</label>
<title>TF-gene-miRNA interactions networks</title>
<p>The TF&#x2013;miRNA coregulatory network for <italic>IRS1</italic> is composed of 48 nodes and 47 edges. The analysis indicates that <italic>IRS1</italic> is modulated by 23&#xa0;TFs and 23 miRNAs (<xref ref-type="fig" rid="F7">Figure 7A</xref>). The TF&#x2013;miRNA coregulatory network for <italic>UBTD1</italic> consists of 31 nodes and 30 edges. The findings demonstrate that <italic>UBTD1</italic> is influenced by 5&#xa0;TFs and 25 miRNAs (<xref ref-type="fig" rid="F7">Figure 7B</xref>).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Development of the regulatory network for hub genes. Integrated TF&#x2013;miRNA interaction networks for <italic>IRS1</italic> <bold>(A)</bold> and <italic>UBTD1</italic> <bold>(B)</bold> are presented. In the diagram, hexagons represent TF, triangles denote miRNA, and ellipses represent mRNAs. <bold>(C)</bold> The protein-chemical interaction network is depicted, where octagon nodes represent chemicals, and proteins that interact with these chemicals are shown as elliptical nodes.</p>
</caption>
<graphic xlink:href="fgene-17-1759563-g007.tif">
<alt-text content-type="machine-generated">Three circular network diagrams labeled A, B, and C illustrate interactions. A and B each have a central red node connected to blue and purple nodes, representing hierarchical relationships. C features two central red nodes linked to numerous yellow nodes, forming dense radial patterns.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-7">
<label>3.7</label>
<title>Protein-chemical interaction networks</title>
<p>Protein-chemical interaction networks are crucial for understanding the mechanisms underlying disease development and can aid in the drug discovery process. In this study, protein-chemical interaction networks for the candidate hub genes were constructed, consisting of 81 nodes and 84 edges. The compounds that interact with both IRS1 and UBTD1 include Aflatoxin B1, Atrazine, Testosterone, Aspirin, and Calcitriol (<xref ref-type="fig" rid="F7">Figure 7C</xref>).</p>
</sec>
<sec id="s3-8">
<label>3.8</label>
<title>Results of single-cell analysis</title>
<p>To explore the potential involvement of <italic>IRS1</italic> and <italic>UBTD1</italic> in SCI at the single-cell resolution, we performed an analysis of the scRNA-seq data from the GSE162610 dataset. A total of 28,936 cells derived from C57BL/6 mouse spinal cord samples were processed, followed by dimensionality reduction, clustering, and t-SNE visualization of the dataset. Through analysis, 31 distinct cell clusters were characterized, and marker genes were identified using the &#x201c;FindAllMarkers&#x201d; package (<xref ref-type="fig" rid="F8">Figure 8A</xref>). Using these marker genes, a total of 162,610 cells were classified into nine distinct cell types: astrocytes, endothelial cells, epithelial cells, granulocytes, macrophages, microglia, monocytes, neurons, and oligodendrocytes (<xref ref-type="fig" rid="F8">Figure 8B</xref>). <italic>Irs1</italic> was predominantly expressed in endothelial and epithelial cells (<xref ref-type="fig" rid="F8">Figures 8C,D</xref>). We found <italic>Ubtd1</italic> expression across multiple cell types, with elevated levels found in endothelial cells and microglia (<xref ref-type="fig" rid="F8">Figures 8E,F</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Single-cell transcriptomic analysis of spinal cord tissue. <bold>(A)</bold> t-SNE-based visualization depicting the distribution of 31 unique cell clusters. <bold>(B)</bold> t-SNE visualization of various cell types including astrocytes, endothelial cells, epithelial cells, granulocytes, macrophages, microglia, monocytes, neurons, and oligodendrocytes. <bold>(C)</bold> t-SNE visualization illustrating the expression pattern of <italic>Irs1</italic>. <bold>(D)</bold> The violin plot illustrates the distribution of <italic>Irs1</italic> expression levels in various cell types. <bold>(E)</bold> t-SNE visualization illustrating the expression pattern of <italic>Ubtd1</italic>. <bold>(F)</bold> The violin plot illustrates the distribution of <italic>Ubtd1</italic> expression levels in various cell types.</p>
</caption>
<graphic xlink:href="fgene-17-1759563-g008.tif">
<alt-text content-type="machine-generated">Composite scientific figure with six panels: A and B feature tSNE plots of single-cell data, displaying clusters either by numeric labels (A) or cell types differentiated by color (B). C and E show gene expression levels of Irs1 and Ubd1, respectively, mapped onto tSNE plots with color gradients. D and F provide corresponding violin plots for Irs1 and Ubd1 expression across annotated cell types, each color-coded to match the tSNE clusters.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-9">
<label>3.9</label>
<title>Experimental evaluation of candidate hub genes in the SCI animal model</title>
<p>To experimentally validate the roles of <italic>IRS1</italic> and <italic>UBTD1</italic> in SCI, we conducted RT-qPCR and Western blot analyses to assess the mRNA and protein levels of <italic>IRS1</italic> and <italic>UBTD1</italic> in spinal tissue from the SCI group compared to the Sham group. qPCR validation revealed a significant upregulation of <italic>Ubtd1</italic> in the SCI group versus the Sham group, consistent with the bioinformatic predictions. In contrast, <italic>Irs1</italic> mRNA levels did not exhibit a statistically significant difference (<xref ref-type="fig" rid="F9">Figure 9A</xref>). Furthermore, the Western blot analysis demonstrated a notable increase in UBTD1 expression in the spinal tissue of the SCI group compared to the Sham group (<xref ref-type="fig" rid="F9">Figure 9B</xref>), confirming its robust dysregulation at both transcriptional and translational levels. Consequently, based on the cross-validation results, UBTD1 was identified as the primary hub gene for further discussion.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>mRNA and protein expression analysis of the two hub genes in the Sham and SCI rat models. <bold>(A)</bold> qRT-PCR analysis of <italic>Irs1</italic> and <italic>Ubtd1</italic> mRNA expression levels in the spinal tissue from the SCI group compared with the Sham group. <bold>(B)</bold> Representative Western blot bands showing UBTD1 protein expression in the Sham and SCI groups. Data are presented as mean &#xb1; SEM. &#x2a;<italic>P</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>P</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>P</italic> &#x3c; 0.001; ns, not significant.</p>
</caption>
<graphic xlink:href="fgene-17-1759563-g009.tif">
<alt-text content-type="machine-generated">Figure with two panels showing quantification of Irs1 and UbtD1 mRNA and UBTD1 protein in Sham and SCI groups. Panel A is a bar graph with scatter points comparing relative mRNA levels of Irs1 and UbtD1; Irs1 shows no significant difference, UbtD1 is significantly increased in SCI. Panel B displays a western blot for UBTD1 and &#x3B2;-Tubulin, with a corresponding bar chart indicating significantly higher UBTD1 protein levels in SCI group compared to Sham.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<label>4</label>
<title>Discussion</title>
<p>SCI is a grievous condition that significantly diminishes the mobility and quality of life for affected individuals (<xref ref-type="bibr" rid="B3">Anjum et al., 2020</xref>). The economic ramifications of SCI are profound, burdening healthcare systems due to the extensive rehabilitation and long-term care demands. Despite significant research aimed at understanding the intricate pathophysiology of SCI and advancing targeted treatments, translating these findings into clinical practice continues to pose substantial challenges (<xref ref-type="bibr" rid="B6">Bhatt and Das, 2025</xref>). Although methylprednisolone is the only pharmacological treatment approved by the FDA for SCI, its substantial side effects limit its therapeutic potential, emphasizing the pressing need for alternative treatment strategies (<xref ref-type="bibr" rid="B24">Karsy and Hawryluk, 2019</xref>). Previous studies have shown that alterations in metabolism, especially those involving glycolysis, can trigger neuroinflammatory reactions in microglia (<xref ref-type="bibr" rid="B22">Hua et al., 2024</xref>). This study investigated the association between GRGs and immune responses in SCI. By employing advanced analytical techniques, including gene expression analyses and machine learning algorithms, this research aimed to identify critical genes associated with glycolysis that may reflect the systemic or local inflammatory status of SCI. Key findings from this study, such as the identification of the candidate hub gene <italic>UBTD1</italic>, may contribute to the development of targeted therapeutic strategies that could enhance recovery following spinal injuries. Understanding the role of glycolysis in SCI provides critical insights into potential therapeutic strategies. The identification of differentially expressed DEGs such as <italic>UBTD1 s</italic>upports their potential significance in the inflammatory processes associated with SCI.</p>
<p>
<italic>IRS1</italic> was initially identified as a candidate gene in our computational analysis. Insulin receptor substrates (IRSs) play a crucial role in mediating insulin signaling pathways, regulating key cellular processes including growth, survival, and metabolic homeostasis (<xref ref-type="bibr" rid="B38">Sesti et al., 2001</xref>). To date, six distinct IRSs have been identified, ranging from IRS1 to IRS6, with IRS1 and IRS2 being the most abundantly expressed in human tissues (<xref ref-type="bibr" rid="B11">Dearth et al., 2007</xref>). Previous investigations have demonstrated that IRS1 are significantly overexpressed in hepatocellular carcinoma and pancreatic cancer, suggesting their potential role in tumorigenesis (<xref ref-type="bibr" rid="B35">Nehrbass et al., 1998</xref>; <xref ref-type="bibr" rid="B5">Bergmann et al., 1996</xref>). Conversely, IRS1 expression has been found to be downregulated in squamous cell lung carcinoma. In contrast, IRS1 exhibits constitutive activation in various sarcomas and breast cancer, highlighting its divergent roles in different cancer types (<xref ref-type="bibr" rid="B8">Chang et al., 2002</xref>). Furthermore, a reduction in IRS1 expression has been observed in mouse models of Alzheimer&#x2019;s disease (<xref ref-type="bibr" rid="B16">Fan et al., 2022</xref>). Activation of IRS1 has been shown to suppress autophagic processes and enhance locomotor recovery following spinal cord injury (<xref ref-type="bibr" rid="B49">Zang et al., 2023</xref>). However, in the context of SCI, the specific role of IRS1 requires further elucidation.</p>
<p>Ubiquitin domain-containing protein 1 (<italic>UBTD1</italic>) is a highly conserved protein across species, known to engage in interactions with E2 ubiquitin-conjugating enzymes within the ubiquitin-proteasome system (<xref ref-type="bibr" rid="B31">Liu et al., 2003</xref>; <xref ref-type="bibr" rid="B41">Uhler et al., 2014</xref>). In gastric cancer, UBTD1 has been shown to promote cellular senescence by enhancing the stability of the p53 protein while facilitating the degradation of Mdm2, thereby modulating key regulatory pathways involved in tumor progression (<xref ref-type="bibr" rid="B51">Zhang et al., 2015</xref>). Reduced expression of UBTD1 has been implicated in the progression of hepatocellular carcinoma, potentially through the modulation of the YAP signaling pathway (<xref ref-type="bibr" rid="B45">Yang et al., 2020</xref>). UBTD1 facilitates the progression of colorectal cancer by enhancing the stability of c-Myc, thereby promoting glycolytic activity and supporting tumor metabolism (<xref ref-type="bibr" rid="B52">Zhao et al., 2024</xref>). Despite the lack of studies on the role of UBTD1 in spinal cord injury, our research provides new insights into its potential involvement, suggesting that UBTD1 could emerge as a novel therapeutic target for spinal cord injury treatment. Our research provides new insights into its potential involvement, suggesting that UBTD1 could emerge as a novel candidate biomarker for spinal cord injury.</p>
<p>Pathway analysis further elucidates the significance of GR-DEGs in SCI. Investigating these pathways could reveal new targets for modulating neuroinflammation, which is a significant barrier to recovery in SCI patients. Moreover, the connection between glycolysis and immune regulation aligns with emerging perspectives on the metabolic reprogramming of immune cells in various conditions, including cancers and chronic inflammatory diseases (<xref ref-type="bibr" rid="B29">Li et al., 2025a</xref>; <xref ref-type="bibr" rid="B30">Li et al., 2025b</xref>; <xref ref-type="bibr" rid="B46">Yang et al., 2025</xref>; <xref ref-type="bibr" rid="B12">Deng et al., 2025</xref>). Moreover, the significant differences in immune cell populations observed using the ssGSEA method highlight the altered immune response in SCI. The increased abundance of activated dendritic cells and macrophages, coupled with a decrease in activated B cells and CD8 T cells, suggests a shift in the immune profile that may contribute to secondary injury processes. This underscores the importance of understanding how metabolic changes in glycolysis can shape immune responses and potentially inform therapeutic strategies aimed at enhancing recovery. By targeting glycolytic pathways, we may be able to restore balance within the immune landscape and improve functional outcomes in SCI patients, a notion that warrants further exploration in clinical settings.</p>
<p>In constructing a protein-chemical interaction network, the identification of compounds such as Testosterone and Aspirin interacting with hub genes <italic>IRS1</italic> and <italic>UBTD1</italic> offers exciting avenues for drug repurposing. Understanding these interactions could facilitate the development of novel therapeutic agents aimed at modulating glycolysis-related pathways in SCI. The implications of these findings extend beyond SCI, as they may also apply to other neurological conditions where metabolic dysregulation plays a pivotal role, highlighting the broader impact of this research on our understanding of metabolic pathways in brain injuries and diseases.</p>
<p>Single-cell analysis revealed that <italic>Irs1</italic> was primarily expressed in endothelial and epithelial cells. Additionally, we observed widespread expression of <italic>Ubtd1</italic> across various cell types, with particularly high levels in endothelial cells and microglia. Activation of microglia serves as a key feature of the secondary inflammatory response after SCI, with microglia-driven inflammation playing a critical role in hindering functional recovery (<xref ref-type="bibr" rid="B13">Devanney et al., 2020</xref>; <xref ref-type="bibr" rid="B2">Al Mamun et al., 2020</xref>). M1-polarized microglia, commonly induced by lipopolysaccharide (LPS), secrete pro-inflammatory factors that significantly impair neuronal viability (<xref ref-type="bibr" rid="B10">David and Kroner, 2011</xref>). On the other hand, M2-polarized microglia facilitate recovery by removing cellular debris via phagocytosis and releasing neurotrophic and protective molecules that promote tissue repair (<xref ref-type="bibr" rid="B17">Gensel et al., 2009</xref>; <xref ref-type="bibr" rid="B34">Lourbopoulos et al., 2015</xref>). Consequently, M2-polarized microglia enhance neuronal repair and functional recovery, while M1-polarized microglia impede these processes (<xref ref-type="bibr" rid="B18">Han et al., 2018</xref>). Alleviating endothelial cell senescence and enhancing recovery following spinal cord injury in diabetic mice (<xref ref-type="bibr" rid="B20">He et al., 2025</xref>). Acute hyperglycemia hampers the recovery of spinal cord injury by inducing excessive ferroptosis in endothelial cells (<xref ref-type="bibr" rid="B43">Wu et al., 2025</xref>). Following spinal cord injury, the alarmin interleukin-1&#x3b1; initiates secondary degeneration by activating reactive astrocytes and endothelial cells (<xref ref-type="bibr" rid="B7">Bretheau et al., 2022</xref>). Collectively, these findings highlight the intricate interplay between endothelial cells, epithelial cells, microglia, and inflammatory mediators in the pathophysiology of spinal cord injury. This understanding may open new avenues for the development of therapeutic strategies targeting spinal cord injury. These findings highlight the potential roles of <italic>IRS1</italic> and <italic>UBTD1</italic> in SCI pathophysiology. However, while the dataset includes valuable temporal data, this study focused on static expression patterns at a single time point, with the goal of providing insights into gene expression at the cellular level. To gain a deeper understanding of the dynamic processes involved in SCI, future studies should leverage the temporal structure of this dataset to investigate dynamic gene regulation, cell-state transitions, such as microglial polarization, and cell&#x2013;cell communication mechanisms. These analyses will be essential for uncovering the underlying mechanistic processes that drive SCI progression and recovery.</p>
<p>To experimentally validate the computational findings, we performed qRT-qPCR and Western blot analyses to compare the expression levels of IRS1 and UBTD1 in spinal tissues from the SCI and Sham groups. <italic>Ubtd1</italic> expression was significantly elevated in the SCI group relative to the Sham group, consistent with the bioinformatic predictions. In contrast, <italic>Irs1</italic> showed no significant alteration in the injured spinal cord tissue. This discrepancy between the blood-based computational prediction and the tissue-based experimental validation suggests that <italic>IRS1</italic> dysregulation might be context-dependent. It is possible that <italic>IRS1</italic> alterations are more prominent in the systemic immune circulation (as detected in the discovery dataset) than in the local spinal cord microenvironment, or that its cell-type-specific expression (in endothelial cells) was masked by the complex cellular heterogeneity of bulk tissue samples. Consequently, given the robust consistency of <italic>UBTD1</italic> across all analytical layers, we prioritize <italic>UBTD1</italic> as the primary candidate hub gene for future investigation.</p>
<p>This study acknowledges several limitations that may impact the generalizability and robustness of the findings. The relatively small sample size may limit the statistical power and the ability to detect subtle but clinically significant effects. Furthermore, the lack of clinical validation analysis raises concerns regarding the translational potential of the identified biomarkers and therapeutic targets.</p>
<p>In addition, the discovery and validation datasets differed in both tissue origin and species, with peripheral blood transcriptomes from human subjects and spinal cord tissues from a rat model, respectively. Peripheral blood gene expression primarily reflects systemic immune and inflammatory states, whereas spinal cord tissue represents the local microenvironment of the central nervous system. Therefore, the validation analyses were restricted to transcriptomic and pathway-level consistency rather than tissue-specific or mechanistic confirmation, and the findings should be interpreted with caution in this context.</p>
<p>Lastly, potential batch effects resulting from the integration of multiple gene expression datasets could introduce confounding variables, necessitating cautious interpretation of the results. Moreover, the current study did not include <italic>in vitro</italic> cellular experiments to validate the functional roles of the identified genes. While these genes were identified through computational analyses, the lack of experimental validation in cell-based models is a limitation, and future studies should include these to confirm the mechanistic roles of the identified key genes in spinal cord injury.</p>
<p>Collectively, these limitations underscore the need for further studies incorporating larger cohorts matched human spinal cord tissues, longitudinal clinical validation, and <italic>in vitro</italic> cellular experiments to further corroborate the current findings and refine our understanding of metabolic&#x2013;immune interactions in spinal cord injury.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<label>5</label>
<title>Conclusion</title>
<p>In conclusion, this study systematically investigated the association between glycolysis-related genes and immune responses mechanisms in spinal cord injury through integrative transcriptomic and experimental analyses, providing pathway-level insights into metabolic alterations associated with SCI. The identification of the hub gene UBTD1 highlights its potential value as candidate biomarker, rather than a definitive mechanistic driver, and points to avenues for future research and hypothesis-driven intervention strategies.</p>
<p>By leveraging advanced analytical techniques, this study adds to the growing body of evidence linking metabolic reprogramming with immune dysregulation in SCI, and suggests that glycolysis-related pathways may represent important components of the post-injury inflammatory landscape. Continued exploration of these findings in larger cohorts, using matched human spinal cord tissues and additional functional experiments, will be essential for translating these observations into clinical practice and ultimately enhancing outcomes for individuals affected by SCI.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The original contributions presented in the study are publicly available. These data can be found in the NCBI Gene Expression Omnibus (GEO) with the accession numbers GSE151371, GSE45006, and GSE162610. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="s7">
<title>Ethics statement</title>
<p>The animal study was approved by Animal Ethics Committee of Yan&#x2019;an University. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>XL: Writing &#x2013; review and editing, Funding acquisition, Software, Writing &#x2013; original draft, Methodology, Conceptualization, Investigation. ZW: Software, Writing &#x2013; review and editing, Investigation. JH: Data curation, Validation, Visualization, Writing &#x2013; review and editing, Investigation, Software. GS: Writing &#x2013; review and editing, Software, Investigation, Methodology, Visualization. XA: Investigation, Writing &#x2013; review and editing, Supervision, Conceptualization.</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s11">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s12">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s13">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2026.1759563/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2026.1759563/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.xlsx" id="SM1" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahuja</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Nori</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kotter</surname>
<given-names>M. R. N.</given-names>
</name>
<name>
<surname>Druschel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Curt</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Traumatic spinal cord injury</article-title>. <source>Nat. Rev. Dis. Prim.</source> <volume>3</volume>, <fpage>17018</fpage>. <pub-id pub-id-type="doi">10.1038/nrdp.2017.18</pub-id>
<pub-id pub-id-type="pmid">28447605</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al Mamun</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ngwa</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sharmeen</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Microglial IRF5-IRF4 regulatory axis regulates neuroinflammation after cerebral ischemia and impacts stroke outcomes</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>117</volume> (<issue>3</issue>), <fpage>1742</fpage>&#x2013;<lpage>1752</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1914742117</pub-id>
<pub-id pub-id-type="pmid">31892541</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anjum</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yazid</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Fauzi Daud</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Idris</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>A. M. H.</given-names>
</name>
<name>
<surname>Selvi Naicker</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>20</issue>). <pub-id pub-id-type="doi">10.3390/ijms21207533</pub-id>
<pub-id pub-id-type="pmid">33066029</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartel</surname>
<given-names>D. P.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>MicroRNAs: genomics, biogenesis, mechanism, and function</article-title>. <source>Cell</source> <volume>116</volume> (<issue>2</issue>), <fpage>281</fpage>&#x2013;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(04)00045-5</pub-id>
<pub-id pub-id-type="pmid">14744438</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergmann</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Funatomi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kornmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Beger</surname>
<given-names>H. G.</given-names>
</name>
<name>
<surname>Korc</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Increased expression of insulin receptor substrate-1 in human pancreatic cancer</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>220</volume> (<issue>3</issue>), <fpage>886</fpage>&#x2013;<lpage>890</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1996.0500</pub-id>
<pub-id pub-id-type="pmid">8607861</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhatt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Advancements in spinal cord injury treatment: integrating drug delivery, biophysical stimulation, cell-based therapies, and tissue engineering approaches</article-title>. <source>ACS Appl. Bio Mater</source>. <volume>8</volume> (<issue>8</issue>), <fpage>6526</fpage>&#x2013;<lpage>6540</lpage>. <pub-id pub-id-type="doi">10.1021/acsabm.5c00459</pub-id>
<pub-id pub-id-type="pmid">40754753</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bretheau</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Castellanos-Molina</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>B&#xe9;langer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kusik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mailhot</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Boisvert</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The alarmin interleukin-1&#x3b1; triggers secondary degeneration through reactive astrocytes and endothelium after spinal cord injury</article-title>. <source>Nat. Commun.</source> <volume>13</volume> (<issue>1</issue>), <fpage>5786</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-022-33463-x</pub-id>
<pub-id pub-id-type="pmid">36184639</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications</article-title>. <source>Cancer Res.</source> <volume>62</volume> (<issue>21</issue>), <fpage>6035</fpage>&#x2013;<lpage>6038</lpage>.<pub-id pub-id-type="pmid">12414625</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crispo</surname>
<given-names>J. A. G.</given-names>
</name>
<name>
<surname>Kuramoto</surname>
<given-names>L. K.</given-names>
</name>
<name>
<surname>Cragg</surname>
<given-names>J. J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Global burden of spinal cord injury: future directions</article-title>. <source>Lancet Neurol.</source> <volume>22</volume> (<issue>11</issue>), <fpage>976</fpage>&#x2013;<lpage>978</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(23)00366-6</pub-id>
<pub-id pub-id-type="pmid">37863598</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>David</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kroner</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Repertoire of microglial and macrophage responses after spinal cord injury</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>12</volume> (<issue>7</issue>), <fpage>388</fpage>&#x2013;<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3053</pub-id>
<pub-id pub-id-type="pmid">21673720</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dearth</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Hadsell</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A. V.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2</article-title>. <source>Cell Cycle</source> <volume>6</volume> (<issue>6</issue>), <fpage>705</fpage>&#x2013;<lpage>713</lpage>. <pub-id pub-id-type="doi">10.4161/cc.6.6.4035</pub-id>
<pub-id pub-id-type="pmid">17374994</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Metabolomics-guided analysis combined with network pharmacology and molecular simulations reveals the mechanism of JHT in treating septic intestinal dysfunction</article-title>. <source>J. Ethnopharmacol.</source> <volume>353</volume>, <fpage>120300</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2025.120300</pub-id>
<pub-id pub-id-type="pmid">40754029</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devanney</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Gensel</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Microglia and macrophage metabolism in CNS injury and disease: the role of immunometabolism in neurodegeneration and neurotrauma</article-title>. <source>Exp. Neurol.</source> <volume>329</volume>, <fpage>113310</fpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2020.113310</pub-id>
<pub-id pub-id-type="pmid">32289316</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Inhibiting SHP2 reduces glycolysis, promotes microglial M1 polarization, and alleviates secondary inflammation following spinal cord injury in a mouse model</article-title>. <source>Neural Regen. Res.</source> <volume>20</volume> (<issue>3</issue>), <fpage>858</fpage>&#x2013;<lpage>872</lpage>. <pub-id pub-id-type="doi">10.4103/NRR.NRR-D-23-01925</pub-id>
<pub-id pub-id-type="pmid">38886958</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edgar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Domrachev</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lash</surname>
<given-names>A. E.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Gene expression omnibus: NCBI gene expression and hybridization array data repository</article-title>. <source>Nucleic Acids Res.</source> <volume>30</volume> (<issue>1</issue>), <fpage>207</fpage>&#x2013;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1093/nar/30.1.207</pub-id>
<pub-id pub-id-type="pmid">11752295</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>C. C.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Bilateral intracerebroventricular injection of streptozotocin induces AD-like behavioral impairments and neuropathological features in mice: involved with the fundamental role of neuroinflammation</article-title>. <source>Biomed. Pharmacother.</source> <volume>153</volume>, <fpage>113375</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2022.113375</pub-id>
<pub-id pub-id-type="pmid">35834993</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gensel</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>van Rooijen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ankeny</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Popovich</surname>
<given-names>P. G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Macrophages promote axon regeneration with concurrent neurotoxicity</article-title>. <source>J. Neurosci.</source> <volume>29</volume> (<issue>12</issue>), <fpage>3956</fpage>&#x2013;<lpage>3968</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3992-08.2009</pub-id>
<pub-id pub-id-type="pmid">19321792</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Plasma hemopexin ameliorates murine spinal cord injury by switching microglia from the M1 state to the M2 state</article-title>. <source>Cell Death Dis.</source> <volume>9</volume> (<issue>2</issue>), <fpage>181</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-017-0236-8</pub-id>
<pub-id pub-id-type="pmid">29415995</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Andersen-Nissen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mauck</surname>
<given-names>W. M.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Integrated analysis of multimodal single-cell data</article-title>. <source>Cell</source> <volume>184</volume> (<issue>13</issue>), <fpage>3573</fpage>&#x2013;<lpage>3587.e29</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id>
<pub-id pub-id-type="pmid">34062119</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Curcumin-loaded milk-derived sEVs fused with platelet membrane attenuate endothelial senescence and promote spinal cord injury recovery in diabetic mice</article-title>. <source>Mater. Today Bio</source> <volume>33</volume>, <fpage>102036</fpage>. <pub-id pub-id-type="doi">10.1016/j.mtbio.2025.102036</pub-id>
<pub-id pub-id-type="pmid">40688662</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Spinal cord injury: molecular mechanisms and therapeutic interventions</article-title>. <source>Signal Transduct. Target Ther.</source> <volume>8</volume> (<issue>1</issue>), <fpage>245</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-023-01477-6</pub-id>
<pub-id pub-id-type="pmid">37357239</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hua</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>PRMT6 deficiency or inhibition alleviates neuropathic pain by decreasing glycolysis and inflammation in microglia</article-title>. <source>Brain Behav. Immun.</source> <volume>118</volume>, <fpage>101</fpage>&#x2013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2024.02.027</pub-id>
<pub-id pub-id-type="pmid">38402915</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Murao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Imachi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ishida</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>MicroRNA networks alter to conform to transcription factor networks adding redundancy and reducing the repertoire of target genes for coordinated regulation</article-title>. <source>Mol. Biol. Evol.</source> <volume>28</volume> (<issue>1</issue>), <fpage>639</fpage>&#x2013;<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msq231</pub-id>
<pub-id pub-id-type="pmid">20805189</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karsy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hawryluk</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Modern medical management of spinal cord injury</article-title>. <source>Curr. Neurol. Neurosci. Rep.</source> <volume>19</volume> (<issue>9</issue>), <fpage>65</fpage>. <pub-id pub-id-type="doi">10.1007/s11910-019-0984-1</pub-id>
<pub-id pub-id-type="pmid">31363857</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korsunsky</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Millard</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Slowikowski</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Fast, sensitive and accurate integration of single-cell data with harmony</article-title>. <source>Nat. Methods</source> <volume>16</volume> (<issue>12</issue>), <fpage>1289</fpage>&#x2013;<lpage>1296</lpage>. <pub-id pub-id-type="doi">10.1038/s41592-019-0619-0</pub-id>
<pub-id pub-id-type="pmid">31740819</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kyritsis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Torres-Esp&#xed;n</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schupp</surname>
<given-names>P. G.</given-names>
</name>
<name>
<surname>Huie</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Duong-Fernandez</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Diagnostic blood RNA profiles for human acute spinal cord injury</article-title>. <source>J. Exp. Med.</source> <volume>218</volume> (<issue>3</issue>), <fpage>e20201795</fpage>. <pub-id pub-id-type="doi">10.1084/jem.20201795</pub-id>
<pub-id pub-id-type="pmid">33512429</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lambert</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Jolma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Campitelli</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Albu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>The human transcription factors</article-title>. <source>Cell</source> <volume>172</volume> (<issue>4</issue>), <fpage>650</fpage>&#x2013;<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2018.01.029</pub-id>
<pub-id pub-id-type="pmid">29425488</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langfelder</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>WGCNA: an R package for weighted correlation network analysis</article-title>. <source>BMC Bioinforma.</source> <volume>9</volume>, <fpage>559</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-9-559</pub-id>
<pub-id pub-id-type="pmid">19114008</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2025a</year>). <article-title>Hybrid cell membrane-functionalized nanoagents synergistically enhance Cuproptosis-Mediated immunotherapy by dual modulation of glycolytic metabolism and tumor microenvironments</article-title>. <source>ACS Nano</source>. <volume>19</volume> (<issue>31</issue>), <fpage>28913</fpage>&#x2013;<lpage>28932</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.5c10671</pub-id>
<pub-id pub-id-type="pmid">40755199</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2025b</year>). <article-title>Endothelial-derived CCL7 promotes macrophage polarization and aggravates septic acute lung injury <italic>via</italic> CCR1-Mediated STAT1 succinylation</article-title>. <source>Adv. Sci. (Weinh)</source> <volume>12</volume>, <fpage>e06209</fpage>. <pub-id pub-id-type="doi">10.1002/advs.202506209</pub-id>
<pub-id pub-id-type="pmid">40755420</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Cloning and identification of a novel human ubiquitin-like protein, DC-UbP, from dendritic cells</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>300</volume> (<issue>3</issue>), <fpage>800</fpage>&#x2013;<lpage>805</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-291x(02)02913-3</pub-id>
<pub-id pub-id-type="pmid">12507522</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z. P.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse</article-title>. <source>Database (Oxford)</source> <volume>2015</volume>, <fpage>2015</fpage>. <pub-id pub-id-type="doi">10.1093/database/bav095</pub-id>
<pub-id pub-id-type="pmid">26424082</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-&#x3ba;B signaling</article-title>. <source>Theranostics</source> <volume>11</volume> (<issue>9</issue>), <fpage>4187</fpage>&#x2013;<lpage>4206</lpage>. <pub-id pub-id-type="doi">10.7150/thno.49054</pub-id>
<pub-id pub-id-type="pmid">33754056</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lourbopoulos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ert&#xfc;rk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hellal</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Microglia in action: how aging and injury can change the brain&#x27;s guardians</article-title>. <source>Front. Cell Neurosci.</source> <volume>9</volume>, <fpage>54</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00054</pub-id>
<pub-id pub-id-type="pmid">25755635</pub-id>
</mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nehrbass</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Klimek</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bannasch</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis</article-title>. <source>Am. J. Pathol.</source> <volume>152</volume> (<issue>2</issue>), <fpage>341</fpage>&#x2013;<lpage>345</lpage>.<pub-id pub-id-type="pmid">9466558</pub-id>
</mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orihuela</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>McPherson</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Harry</surname>
<given-names>G. J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Microglial M1/M2 polarization and metabolic states</article-title>. <source>Br. J. Pharmacol.</source> <volume>173</volume> (<issue>4</issue>), <fpage>649</fpage>&#x2013;<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13139</pub-id>
<pub-id pub-id-type="pmid">25800044</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabogal-Gu&#xe1;queta</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Marmolejo-Garza</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Trombetta-Lima</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Oun</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hunneman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction</article-title>. <source>Nat. Commun.</source> <volume>14</volume> (<issue>1</issue>), <fpage>6454</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-023-42096-7</pub-id>
<pub-id pub-id-type="pmid">37833292</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sesti</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Federici</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hribal</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Lauro</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sbraccia</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lauro</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Defects of the insulin receptor substrate (IRS) system in human metabolic disorders</article-title>. <source>Faseb J.</source> <volume>15</volume> (<issue>12</issue>), <fpage>2099</fpage>&#x2013;<lpage>2111</lpage>. <pub-id pub-id-type="doi">10.1096/fj.01-0009rev</pub-id>
<pub-id pub-id-type="pmid">11641236</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stelzer</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Plaschkes</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Twik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fishilevich</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>The GeneCards suite: from gene data mining to disease genome sequence analyses</article-title>. <source>Curr. Protoc. Bioinforma.</source> <volume>54</volume>, <fpage>30</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1002/cpbi.5</pub-id>
<pub-id pub-id-type="pmid">27322403</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>m(6)A methylation modification patterns and tumor microenvironment infiltration characterization in pancreatic cancer</article-title>. <source>Front. Immunol.</source> <volume>12</volume>, <fpage>739768</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2021.739768</pub-id>
<pub-id pub-id-type="pmid">34616403</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uhler</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Sp&#xe5;hr</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Farge</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Clavel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>N. G.</given-names>
</name>
<name>
<surname>Falkenberg</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>The UbL protein UBTD1 stably interacts with the UBE2D family of E2 ubiquitin conjugating enzymes</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>443</volume> (<issue>1</issue>), <fpage>7</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2013.10.137</pub-id>
<pub-id pub-id-type="pmid">24211586</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viola</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Munari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>S&#xe1;nchez-Rodr&#xed;guez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Scolaro</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Castegna</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The metabolic signature of macrophage responses</article-title>. <source>Front. Immunol.</source> <volume>10</volume>, <fpage>1462</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.01462</pub-id>
<pub-id pub-id-type="pmid">31333642</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Acute hyperglycemia impedes spinal cord injury recovery via triggering excessive ferroptosis of endothelial cells</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>301</volume>, <fpage>140453</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2025.140453</pub-id>
<pub-id pub-id-type="pmid">39884601</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>E. E.</given-names>
</name>
<name>
<surname>Hancock</surname>
<given-names>R. E.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data</article-title>. <source>Nat. Protoc.</source> <volume>10</volume> (<issue>6</issue>), <fpage>823</fpage>&#x2013;<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2015.052</pub-id>
<pub-id pub-id-type="pmid">25950236</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway</article-title>. <source>Theranostics</source> <volume>10</volume> (<issue>13</issue>), <fpage>5790</fpage>&#x2013;<lpage>5801</lpage>. <pub-id pub-id-type="doi">10.7150/thno.44789</pub-id>
<pub-id pub-id-type="pmid">32483419</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Research progress on the interaction between glucose metabolic reprogramming and lactylation in tumors</article-title>. <source>Front. Immunol.</source> <volume>16</volume>, <fpage>1595162</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2025.1595162</pub-id>
<pub-id pub-id-type="pmid">40755753</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Metabolic reprogramming and polarization of microglia in Parkinson&#x27;s disease: role of inflammasome and iron</article-title>. <source>Ageing Res. Rev.</source> <volume>90</volume>, <fpage>102032</fpage>. <pub-id pub-id-type="doi">10.1016/j.arr.2023.102032</pub-id>
<pub-id pub-id-type="pmid">37572760</pub-id>
</mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaborowski</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Walther</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Determinants of correlated expression of transcription factors and their target genes</article-title>. <source>Nucleic Acids Res.</source> <volume>48</volume> (<issue>20</issue>), <fpage>11347</fpage>&#x2013;<lpage>11369</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa927</pub-id>
<pub-id pub-id-type="pmid">33104784</pub-id>
</mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Tenuigenin activates the IRS1/Akt/mTOR signaling by blocking PTPN1 to inhibit autophagy and improve locomotor recovery in spinal cord injury</article-title>. <source>J. Ethnopharmacol.</source> <volume>317</volume>, <fpage>116841</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2023.116841</pub-id>
<pub-id pub-id-type="pmid">37355079</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>RCircos: an R package for Circos 2D track plots</article-title>. <source>BMC Bioinforma.</source> <volume>14</volume>, <fpage>244</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-14-244</pub-id>
<pub-id pub-id-type="pmid">23937229</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X. W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X. F.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L. Q.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>R. X.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop</article-title>. <source>J. Pathol.</source> <volume>235</volume> (<issue>4</issue>), <fpage>656</fpage>&#x2013;<lpage>667</lpage>. <pub-id pub-id-type="doi">10.1002/path.4478</pub-id>
<pub-id pub-id-type="pmid">25382750</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>The ubiquitin-like protein UBTD1 promotes colorectal cancer progression by stabilizing c-Myc to upregulate glycolysis</article-title>. <source>Cell Death Dis.</source> <volume>15</volume> (<issue>7</issue>), <fpage>502</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-024-06890-5</pub-id>
<pub-id pub-id-type="pmid">39003255</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tuszynski</surname>
<given-names>M. H.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Regulation of axonal regeneration after mammalian spinal cord injury</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source> <volume>24</volume> (<issue>6</issue>), <fpage>396</fpage>&#x2013;<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-022-00562-y</pub-id>
<pub-id pub-id-type="pmid">36604586</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/711875/overview">Nguyen Quoc Khanh Le</ext-link>, Taipei Medical University, Taiwan</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3096816/overview">Chaochen Li</ext-link>, Nantong First People&#x2019;s Hospital, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3188078/overview">Jalilah Idris</ext-link>, Universiti Kuala Lumpur - Royal College of Medicine Perak, Malaysia</p>
</fn>
</fn-group>
</back>
</article>